MEK nuclear localization promotes YAP stability via sequestering β-TrCP in KRAS mutant cancer cells

Tumours manage to survive the ablation of mutant KRAS, despite the development of KRAS-targeted drugs. Here we describe that inhibition of mutant KRAS promotes MEK nuclear localization as an alternative mechanism of KRAS-targeted drugs resistance. Tissue microarray analysis in colon tumours shows th...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Huanji, Zhou, Sheng, Xia, Hongwei, Yu, Huangfei, Tang, Qiulin, Bi, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889282/
https://www.ncbi.nlm.nih.gov/pubmed/30833665
http://dx.doi.org/10.1038/s41418-019-0309-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889282/
https://www.ncbi.nlm.nih.gov/pubmed/30833665
http://dx.doi.org/10.1038/s41418-019-0309-6

Ejemplares similares